Preliminary findings from a “mix-and-match” clinical trial of COVID-19 vaccines showed that people who received a first dose of the AstraZeneca vaccine and a second dose of the Moderna vaccine have higher antibody levels than those who received two doses of the AstraZeneca vaccine, Central Epidemic Command Center (CECC) specialist advisory panel convener Chang Shan-chwen (張上淳) said yesterday.
The clinical trial conducted by National Taiwan University (NTU) Hospital recruited 400 participants, who were divided into four groups of 100 people each, Chang, an NTU executive vice president, told reporters on the sidelines of the 10th TEPHINET Southeast Asia/Western Pacific Bi-Regional Scientific Conference in Taipei.
The first group was given two doses of the AstraZeneca vaccine, eight weeks apart; the second group had two doses of the Moderna vaccine, four weeks apart; while the remaining two were given one dose of the AstraZeneca vaccine, followed by a dose of the Moderna vaccine, four weeks and eight weeks apart, Chang said.
Photo: CNA
Antibody tests conducted on the 14th day and the 28th day after the participants received a second dose have been completed, but a third test to be conducted three months after their second dose has yet to be done, he said.
Based on the first two antibody tests, people who received the AstraZeneca-Moderna combination have higher neutralizing antibody titers (levels) than those who received two doses of the AstraZeneca vaccine, but they are about the same as those who received two doses of Moderna, Chang said.
There were also more people in the AstraZeneca-Moderna combination groups who reported post-vaccination side effects than people in the groups who received two doses of the same vaccine, he said.
While a higher percentage of people who received the AstraZeneca-Moderna combination experienced side effects, the severity of the side effects was about the same, he added.
Moreover, when comparing the two AstraZeneca-Moderna combination groups, people who received the two doses eight weeks apart had slightly higher antibody levels than those who received them four weeks apart, so extending the interval a little longer should be acceptable, he said.
At the CECC’s daily news briefing yesterday, Centers for Disease Control Deputy Director-General Chuang Jen-hsiang (莊人祥) said the center is considering allowing the public to receive a mix of the AstraZeneca and Moderna vaccines from later this month.
At present, only medical workers have the option of choosing Moderna for their second shot after receiving an AstraZeneca jab at least 10 weeks earlier.
The CECC late last month said that it would this month offer the public the option to receive the AstraZeneca vaccine as their first dose and the Pfizer-BioNTech vaccine as the second.
Additional reporting by CNA
The US Department of State yesterday criticized Beijing over its misrepresentation of the US’ “one China” policy in the latest diplomatic salvo between the two countries over a bid by Taiwan to regain its observer status at the World Health Assembly, the decisionmaking body of the WHO. “The PRC [People’s Republic of China] continues to publicly misrepresent U.S. policy,” Department of State spokesman Ned Price wrote on Twitter. “The United States does not subscribe to the PRC’s ‘one China principle’ — we remain committed to our longstanding, bipartisan one China policy, guided by the Taiwan Relations Act, Three Joint Communiques, and
FATES LINKED: The US president said that sanctions on Russia over Ukraine must exact a ‘long-term price,’ because otherwise ‘what signal does that send to China?’ US President Joe Biden yesterday vowed that US forces would defend Taiwan militarily in the event of a Chinese attack in his strongest statement to date on the issue. Beijing is already “flirting with danger,” Biden said following talks with Japanese Prime Minister Fumio Kishida in Tokyo, in which the pair agreed to monitor Chinese naval activity and joint Chinese-Russian exercises. Asked if Washington was willing to get involved militarily to defend Taiwan, he replied: “Yes.” “That’s the commitment we made,” Biden said. “We agreed with the ‘one China’ policy, we signed on to it ... but the idea that it can be
SUBTLE? While Biden said the US policy of ‘strategic ambiguity’ on Taiwan had not changed, the group targeted China and Russia without naming them Leaders of Australia, India, Japan and the US yesterday warned against attempts to “change the status quo by force,” as concerns grow about whether China could invade Taiwan. The issue of Taiwan loomed over a leadership meeting in Tokyo of the Quadrilateral Security Dialogue (Quad) nations — the US, Japan, Australia and India — who stressed their determination to ensure a free and open Indo-Pacific region in the face of an increasingly assertive China, although Japanese Prime Minister Fumio Kishida said the group was not targeting any one country. The four leaders said in a joint statement issued after their talks
Nearly half of Taiwanese believe President Tsai Ing-wen (蔡英文) has not done enough to prepare the nation against Chinese aggression, the a poll released yesterday by the Taiwanese Public Opinion Foundation showed. Asked whether the Tsai administration’s military and non-military preparations to defend Taiwan are adequate, 30.6 percent said they were “mostly inadequate” and 18.9 percent said they “very inadequate,” while 25.7 percent said they were “mostly adequate” and 7.1 percent said they were “very adequate.” Another 17.6 percent had no opinion or did not know enough to form a judgement. Still, 51 percent of respondents approved of Tsai’s national defense policy,
RSS